These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11185648)

  • 21. [Evaluation scales for Parkinson's disease].
    Krystkowiak P
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():52-62. PubMed ID: 10916037
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonmotor symptoms in sporadic versus familial forms of Parkinson's disease.
    Chao YX; Chew LM; Deng X; Tan EK
    Neurodegener Dis Manag; 2015; 5(2):147-53. PubMed ID: 25894878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioural and psychological symptoms of dementia associated with Parkinson's disease.
    Leroi I; Burns A
    J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):2-3. PubMed ID: 16954135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E genotype in familial Parkinson's disease. The French Parkinson's Disease Genetics Study Group.
    The F
    J Neurol Neurosurg Psychiatry; 1997 Sep; 63(3):394-5. PubMed ID: 9328263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shifting ability in Parkinson's disease: does shifting ability really deteriorate?
    Tamaru F; Yanagisawa N
    Adv Neurol; 1990; 53():317-20. PubMed ID: 2239470
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intellectual dysfunction in Parkinson's disease--application of "Kanahiroi" test].
    Yamada T; Furumoto H; Hirayama K
    Rinsho Shinkeigaku; 1986 Jun; 26(6):554-8. PubMed ID: 3769304
    [No Abstract]   [Full Text] [Related]  

  • 27. The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease.
    Armstrong MJ; Duff-Canning S; Tang-Wai DF; Fox S; Zadikoff C; Kennedy N; Gill D; Eslinger PJ; Mapstone M; Chou KL; Persad C; Litvan I; Mast BT; Marras C
    Parkinsonism Relat Disord; 2013 Apr; 19(4):463-5. PubMed ID: 23036511
    [No Abstract]   [Full Text] [Related]  

  • 28. [Importance of vascular factors for cognitive rehabilitation in Parkinson's disease patients].
    Slobodin TN
    Lik Sprava; 2012; (7):176-9. PubMed ID: 23350146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial risks of hospitalization for Parkinson's disease in first-degree relatives: a nationwide follow-up study from Sweden.
    Sundquist K; Li X; Hemminki K
    Neurogenetics; 2006 Nov; 7(4):231-7. PubMed ID: 16944085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution and profile of dementia in Parkinson's disease.
    Ross HF; Hughes TA; Boyd JL; Biggins CA; Madeley P; Mindham RH; Spokes EG
    Adv Neurol; 1996; 69():343-7. PubMed ID: 8615150
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuropsychological disorders in Parkinson's disease: evaluating them and their impact on the caregiver].
    Martínez-Martín P; Guerrero-Díaz MT; Frades-Payo B
    Rev Neurol; 2004 Oct 1-15; 39(7):639-45. PubMed ID: 15490351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological impairments associated with severity of Parkinson's disease.
    Huber SJ; Freidenberg DL; Shuttleworth EC; Paulson GW; Christy JA
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):154-8. PubMed ID: 2521056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Physical symptoms of Parkinson's disease and the score on Beck's Depression Inventory].
    Emanuels-Zuurveen ES; Brouwer WH; Lakke JP; Bouhuys AL
    Tijdschr Gerontol Geriatr; 1991 Aug; 22(4):134-8. PubMed ID: 1926297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "closing-in" phenomenon in Parkinson's disease dementia and lewy-body dementia.
    Poletti M; Lucetti C; Del Dotto P; Borelli P; Baldacci F; Logi C; Bonuccelli U
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E38-9. PubMed ID: 23224479
    [No Abstract]   [Full Text] [Related]  

  • 35. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE; Williams DR; Anderson JF
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropsychological studies of patients with Parkinson's disease after stereotaxic operation on the subcortical nuclei].
    Buklina SB; Shabalov VA
    Zh Vopr Neirokhir Im N N Burdenko; 2003; (4):32-6; discussion 36-7. PubMed ID: 14959653
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychopathological features in patients with Parkinson's disease and related caregivers' burden.
    Stella F; Banzato CE; Quagliato EM; Viana MA; Christofoletti G
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1158-65. PubMed ID: 19319995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automatic behavior in Parkinson's disease.
    Fusegi K; Yoritaka A; Hattori N; Mori H
    Parkinsonism Relat Disord; 2015 Jan; 21(1):84-5. PubMed ID: 25466403
    [No Abstract]   [Full Text] [Related]  

  • 39. Mild cognitive impairment in Parkinson's disease: millstone or milestone?
    Burn DJ; Barker RA
    Pract Neurol; 2013 Apr; 13(2):68-9. PubMed ID: 23468557
    [No Abstract]   [Full Text] [Related]  

  • 40. Modification of emotional states by bilateral stimulation of the subthalamic nucleus in a patient with Parkinson's disease.
    Boon P; Dandachi-FitzGerald B; Duits A; Temel Y; Visser-Vandewalle V; van den Hout M
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):117-8. PubMed ID: 20547630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.